Marta Giovanetti

Dr. Marta Giovanetti

Oswaldo Cruz Foundation, FIOCRUZ, Manguinhos 21040-900, RJ, Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2021 in Nature
Verified
Journal Article
Closed access
PDF file
HTHouriiyah Tegally
Houriiyah Tegally
EWEduan Wilkinson
Eduan Wilkinson
Marta GiovanettiMarta Giovanetti
Marta Giovanetti
AIArash Iranzadeh
Arash Iranzadeh
Vagner FonsecaVagner Fonseca
Vagner Fonseca
TOTulio De Oliveira
Tulio De Oliveira

24 May 2017 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JQJoshua Quick
Joshua Quick
NGNathan D Grubaugh
Nathan D Grubaugh
SPSteven T Pullan
Steven T Pullan
ICIngra M Claro
Ingra M Claro
ASAndrew D Smith
Andrew D Smith
NLNicholas J Loman
Nicholas J Loman

15 April 2016 in Science
Verified
Journal Article
Closed access
PDF file
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
RARaimunda Do Socorro da Silva Azevedo
Raimunda Do Socorro da Silva Azevedo
MKMoritz U. G. Kraemer
Moritz U. G. Kraemer
RSRenato Souza
Renato Souza
MCMariana Sequetin Cunha
Mariana Sequetin Cunha
PVPedro Vasconcelos
Pedro Vasconcelos
Zika virus genomes from Brazil: The Zika virus outbreak is a major cause for concern in Brazil, where it has been linked with increased reports of otherwise rare birth defects and neuropathology. In a phylogenetic analysis, Faria et al. infer a single introduction of Zika to the Americas and estimated the introduction date to be about May to December 2013—some 12 months earlier than the virus was reported. This timing correlates with major events in the Brazilian cultural calendar associated with increased traveler numbers from areas where Zika virus has been circulating. A correlation was also observed between incidences of microcephaly and week 17 of pregnancy. Science , this issue p. 345

27 June 2022 in Nature Medicine
Verified
Journal Article
Open access
PDF file
HTHouriiyah Tegally
Houriiyah Tegally
MMMonika Moir
Monika Moir
JEJosie Everatt
Josie Everatt
Marta GiovanettiMarta Giovanetti
Marta Giovanetti
CSCathrine Scheepers
Cathrine Scheepers
TOTulio De Oliveira
Tulio De Oliveira
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth Coronavirus Disease 2019 (COVID-19) wave. We have now identified two new lineages, BA.4 and BA.5, responsible for a fifth wave of infections. The spike proteins of BA.4 and BA.5 are identical, and similar to BA.2 except for the addition of 69–70 deletion (present in the Alpha variant and the BA.1 lineage), L452R (present in the Delta variant), F486V and the wild-type amino acid at Q493. The two lineages differ only outside of the spike region. The 69–70 deletion in spike allows these lineages to be identified by the proxy marker of S-gene target failure, on the background of variants not possessing this feature. BA.4 and BA.5 have rapidly replaced BA.2, reaching more than 50% of sequenced cases in South Africa by the first week of April 2022. Using a multinomial logistic regression model, we estimated growth advantages for BA.4 and BA.5 of 0.08 (95% confidence interval (CI): 0.08–0.09) and 0.10 (95% CI: 0.09–0.11) per day, respectively, over BA.2 in South Africa. The continued discovery of genetically diverse Omicron lineages points to the hypothesis that a discrete reservoir, such as human chronic infections and/or animal hosts, is potentially contributing to further evolution and dispersal of the virus.

24 May 2017 in Nature
Verified
Journal Article
Open access
PDF file
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
JQJ. Quick
J. Quick
ICI.M. Claro
I.M. Claro
JTJulien Thézé
Julien Thézé
JJJ. G. de Jesus
J. G. de Jesus
OPO. G. Pybus
O. G. Pybus
Virus genomes reveal the establishment of Zika virus in Brazil and the Americas, and provide an appropriate timeframe for baseline (pre-Zika) microcephaly in different regions. Three papers in this issue present a wealth of new Zika virus (ZIKV) genome sequences and further insights into the genetic epidemiology of ZIKV. Nathan Grubaugh et al. provide 39 new ZIKV genome sequences from infected patients and Aedes aegypti mosquitoes in Florida. Phylogenetic analysis suggests that the virus has been introduced on multiple separate occasions, probably linked to travel from the Caribbean. They find a low probability of long-term persistence of ZIKV transmission chains within Florida, suggesting that the potential for future ZIKV outbreaks there will depend on transmission dynamics in the Americas. Nuno Faria et al. and Hayden Metsky et al. reconstruct the spread of ZIKV in Brazil and the Americas. Faria et al. provide 54 new ZIKV genomes, several sequenced in real time in a mobile genomics laboratory. They trace the spatial origins and spread of ZIKV in Brazil and the Americas and date the timing of the international spread of ZIKV from Brazil. They find that northeast Brazil had a crucial role in the establishment of the epidemic and the spread of the virus within Brazil and the Americas. Metsky et al. generate 110 ZIKV genomes from clinical and mosquito samples from ten regions. They also see rapid expansion of the epidemic within Brazil and multiple introductions to other geographic areas. In agreement with Faria et al., they find that ZIKV circulated unobserved for many months before transmission was detected. Metsky et al. additionally describe ZIKV evolution and discuss how the accumulation of mutations might affect the performance of diagnostic tests in the future. Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil1. Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease3. However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.

2 February 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
HTHouriiyah Tegally
Houriiyah Tegally
EWEduan Wilkinson
Eduan Wilkinson
RLRichard Lessells
Richard Lessells
JGJennifer Giandhari
Jennifer Giandhari
SPSureshnee Pillay
Sureshnee Pillay
TOTulio De Oliveira
Tulio De Oliveira